RSV Infected Cell Extract Lot E0627128
| Virus Strain | Long |
| Host Cell | Normal Human Dermal Fibroblast (NHDF) |
| Cell Line Characterization | Confirmed Negative for HIV and Hepatitis B |
| Purity | Infected cell extract enriched for viral proteins |
| Inactivation | Verified by tissue culture infectivity assay. |
| Supplied In | 100 mM Glycine pH 9.5 |
| Protein Concentration | 0.5 mg/ml |
| Fill Volume | 1.03 ml (RV135-1) or 25.2 ml (RV135-25) |
| ELISA (IgG) Titer | >1:1600 |
| Western Blot Titer | 10 µg/cm |
| Reference and/or Additional Reading | Chanock R, et al. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am. J. Hyg. 66: 281-290, 1957. |
{mijoshop id=357}
{mijoshop id=358}
ELISA Results
Antigen is Virusys # RV135 RSV Infected Cell Extract coated at various dilutions in PBS. Primary antibodies (CM01 - CM08) are human plasmas previously characterized for RSV IgG serology.
Western Blot Results
Antigen is Virusys # RV135 RSV Infected Cell Extract at 10 µg/cm. Primary antibodies (CM01 - CM08) are human plasmas previously characterized for RSV IgG serology.
This product is intended for research and manufacturing uses only. It is not a diagnostic device. It is supplied frozen on dry ice - upon receipt, store at -70°C. Product degradation will result from multiple freeze/thaw cycles. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use. Storage at 2 - 8°C for up to twelve hours is acceptable for unused portions.
